Supportive therapies
Denosumab (XGEVA) Solid Tumours Protocol V1.1
Glucarpidase (Voraxaze®) Treatment of High Dose Methotrexate Toxicity Protocol V1.1
Infliximab for Immune Mediated Toxicities V3.0
Sandostatin LAR (Octreotide) Protocol V1.0
Somatuline Autogel® (Lanreotide) Protocol V1.0
Use of White Blood Cell Growth Factors in the Treatment of Solid Tumours Procedure V1.1